A. D. Beadell Investment Counsel Inc. Lowers Position in Grail, Inc. (NASDAQ:GRAL)

A. D. Beadell Investment Counsel Inc. cut its stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) by 35.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,681 shares of the company's stock after selling 8,457 shares during the quarter. A. D. Beadell Investment Counsel Inc.'s holdings in Grail were worth $400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in the stock. State of Tennessee Department of Treasury bought a new stake in shares of Grail during the 4th quarter worth $28,000. Lindbrook Capital LLC bought a new stake in Grail during the fourth quarter worth about $28,000. Sterling Capital Management LLC bought a new stake in Grail during the fourth quarter worth about $29,000. Wellington Shields Capital Management LLC bought a new stake in Grail in the 4th quarter worth approximately $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Grail in the 4th quarter worth approximately $41,000.

Insider Activity at Grail

In other Grail news, CEO Robert P. Ragusa sold 94,035 shares of the company's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $3,190,607.55. Following the completion of the transaction, the chief executive officer now directly owns 734,627 shares in the company, valued at approximately $24,925,894.11. This represents a 11.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 48,213 shares of the company's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,635,867.09. Following the completion of the transaction, the president now owns 511,460 shares of the company's stock, valued at $17,353,837.80. This trade represents a 8.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 183,398 shares of company stock worth $6,222,694 over the last quarter. 1.85% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

GRAL has been the subject of a number of recent research reports. Morgan Stanley boosted their target price on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group boosted their price objective on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

Grail Stock Down 1.3%

NASDAQ:GRAL opened at $39.49 on Friday. The firm has a market capitalization of $1.42 billion and a P/E ratio of -0.65. The company has a fifty day moving average of $32.98 and a 200 day moving average of $28.97. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The business had revenue of $31.84 million for the quarter, compared to the consensus estimate of $35.80 million. As a group, analysts anticipate that Grail, Inc. will post -15.15 EPS for the current year.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.